Predictive biomarkers with isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma.

Publication Title

Blood Cancer J

Authors

Paul G Richardson
Thierry Facon
William I Bensinger, Myeloma & Transplant Program, Swedish Cancer Institute, Seattle, WAFollow
Xavier Leleu
Frank Campana
Sandrine Macé
Marielle Chiron
Helgi van de Velde
Joseph Mikhael

Document Type

Article

Publication Date

3-12-2021

Keywords

washington; seattle; swedish cancer

Clinical Institute

Cancer

Specialty

Hematology

Specialty

Oncology